26 related articles for article (PubMed ID: 20683100)
1. Effect of the simultaneous administration of glucocorticoids and IL-15 on human NK cell phenotype, proliferation and function.
Moustaki A; Argyropoulos KV; Baxevanis CN; Papamichail M; Perez SA
Cancer Immunol Immunother; 2011 Dec; 60(12):1683-95. PubMed ID: 21706285
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-15 enhances natural killer cell cytotoxicity in patients with acute myeloid leukemia by upregulating the activating NK cell receptors.
Szczepanski MJ; Szajnik M; Welsh A; Foon KA; Whiteside TL; Boyiadzis M
Cancer Immunol Immunother; 2010 Jan; 59(1):73-9. PubMed ID: 19526239
[TBL] [Abstract][Full Text] [Related]
3. Successful "in-flight" activation of natural killer cells during long-distance shipping.
Koepsell SA; Kadidlo DM; Fautsch S; McCullough J; Klingemann H; Wagner JE; Miller JS; McKenna DH
Transfusion; 2013 Feb; 53(2):398-403. PubMed ID: 22574659
[TBL] [Abstract][Full Text] [Related]
4. Preclinical characterization of DUOC-01, a cell therapy product derived from banked umbilical cord blood for use as an adjuvant to umbilical cord blood transplantation for treatment of inherited metabolic diseases.
Kurtzberg J; Buntz S; Gentry T; Noeldner P; Ozamiz A; Rusche B; Storms RW; Wollish A; Wenger DA; Balber AE
Cytotherapy; 2015 Jun; 17(6):803-815. PubMed ID: 25770677
[TBL] [Abstract][Full Text] [Related]
5. Effect of cyclosporin A on interleukin-15-activated umbilical cord blood natural killer cell function.
Lin SJ; Kuo ML
Cytotherapy; 2008; 10(4):397-405. PubMed ID: 18574772
[TBL] [Abstract][Full Text] [Related]
6. Effect of interleukin-15 and Flt3-ligand on natural killer cell expansion and activation: umbilical cord vs. adult peripheral blood mononuclear cells.
Lin SJ; Yang MH; Chao HC; Kuo ML; Huang JL
Pediatr Allergy Immunol; 2000 Aug; 11(3):168-74. PubMed ID: 10981526
[TBL] [Abstract][Full Text] [Related]
7. Differential expansion of umbilical cord blood mononuclear cell-derived natural killer cells dependent on the dose of interleukin-15 with Flt3L.
Nagamura-Inoue T; Mori Y; Yizhou Z; Watanabe N; Takahashi TA
Exp Hematol; 2004 Feb; 32(2):202-9. PubMed ID: 15102482
[TBL] [Abstract][Full Text] [Related]
8. Characterization of natural killer and natural killer-like T cells derived from ex vivo expanded and activated cord blood mononuclear cells: implications for adoptive cellular immunotherapy.
Ayello J; van de Ven C; Cairo E; Hochberg J; Baxi L; Satwani P; Cairo MS
Exp Hematol; 2009 Oct; 37(10):1216-29. PubMed ID: 19638292
[TBL] [Abstract][Full Text] [Related]
9. Cord blood CD16+56- cells with low lytic activity are possible precursors of mature natural killer cells.
Gaddy J; Broxmeyer HE
Cell Immunol; 1997 Sep; 180(2):132-42. PubMed ID: 9341743
[TBL] [Abstract][Full Text] [Related]
10. Cytotoxicity of human cord blood natural killer cells is enhanced by recombinant interleukin-15.
Saghafi S; Pourfathollah AA; Kheirandish M; Azimdoust A; Behnia M; Shahjahani M; Moin M
Iran J Allergy Asthma Immunol; 2010 Jun; 9(2):69-77. PubMed ID: 20683100
[TBL] [Abstract][Full Text] [Related]
11. Functional analyses of cord blood natural killer cells and T cells: a distinctive interleukin-18 response.
Nomura A; Takada H; Jin CH; Tanaka T; Ohga S; Hara T
Exp Hematol; 2001 Oct; 29(10):1169-76. PubMed ID: 11602318
[TBL] [Abstract][Full Text] [Related]
12. Cytotoxic function of umbilical cord blood natural killer cells: relevance to adoptive immunotherapy.
Lin SJ; Kuo ML
Pediatr Hematol Oncol; 2011 Nov; 28(8):640-6. PubMed ID: 21970456
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
